Mobile App

Google Play Apple Store
Clinical Clips from EASL Congress 2025: Key Breakthroughs in the Treatment of Primary Biliary Cholangitis*
AMA/ABS/ANCC/ACPE-Clinical Clips
There continues to be significant progress in the treatment of primary biliary cholangitis (PBC) and these Clinical Clips from EASL 2025 have focused on the most impactful data presented at this conference. Dr. Nancy Reau will summarize key advances from EASL 2025 and describe their implications for clinical practice. 
Review the activity and claim AMA, ABS, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.








 
Nancy Reau, MD Nancy Reau, MD
Section Chief Professor of Medicine
Richard B. Capps MD, Professorship of Hepatology
Rush University Medical Center

* This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the European Association for the Study of the Liver (EASL) Congress 2025.
20
Supported by independent educational grants from Intercept Pharmaceuticals, Inc. & Ipsen Biopharmaceuticals, Inc.

Launch Date: May 9, 2025
Release Date:May 9, 2025
Expiration Date: April 30, 2026

Mini Module
7915
2025_CC_EASL_PBC_1730x162.gif
True
Liver Disease

CookieConsent

Change Settings